Ligand Pharmaceuticals (LGND) Revenue (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.31% |
| Dec 31, 2025 | -48.32% |
| Sep 30, 2025 | 142.43% |
| Jun 30, 2025 | 5.06% |
| Mar 31, 2025 | 5.89% |
| Dec 31, 2024 | -17.37% |
| Sep 30, 2024 | 24.76% |
| Jun 30, 2024 | 34.07% |
| Mar 31, 2024 | 10.24% |
| Dec 31, 2023 | -14.50% |
| Sep 30, 2023 | 24.66% |
| Jun 30, 2023 | -40.05% |
| Mar 31, 2023 | -12.71% |
| Dec 31, 2022 | -14.93% |
| Sep 30, 2022 | 18.14% |
| Jun 30, 2022 | 37.27% |
| Mar 31, 2022 | -35.26% |
| Dec 31, 2021 | -5.51% |
| Sep 30, 2021 | -24.30% |
| Jun 30, 2021 | 69.24% |
| Mar 31, 2021 | -33.43% |
| Dec 31, 2020 | 67.25% |
| Sep 30, 2020 | 1.03% |
| Jun 30, 2020 | 24.91% |
| Mar 31, 2020 | 22.80% |
| Dec 31, 2019 | 8.85% |
| Sep 30, 2019 | -0.72% |
| Jun 30, 2019 | -42.54% |
| Mar 31, 2019 | -27.03% |
| Dec 31, 2018 | 30.50% |
| Sep 30, 2018 | -49.29% |
| Jun 30, 2018 | 60.34% |
| Mar 31, 2018 | -5.76% |
| Dec 31, 2017 | 30.50% |
| Sep 30, 2017 | -49.29% |
| Jun 30, 2017 | 60.34% |
| Mar 31, 2017 | 47.07% |
| Dec 31, 2016 | 76.63% |
| Sep 30, 2016 | 10.75% |
| Jun 30, 2016 | -34.16% |
| Mar 31, 2016 | 39.90% |
| Dec 31, 2015 | 19.73% |
| Sep 30, 2015 | -3.89% |
| Jun 30, 2015 | 26.13% |
| Mar 31, 2015 | -36.51% |
| Dec 31, 2014 | 53.60% |
| Sep 30, 2014 | 41.15% |
| Jun 30, 2014 | -33.53% |
| Mar 31, 2014 | 8.29% |
| Dec 31, 2013 | 13.32% |
| Sep 30, 2013 | 35.75% |
| Jun 30, 2013 | -17.78% |
| Mar 31, 2013 | -14.55% |
| Dec 31, 2012 | 113.88% |
| Sep 30, 2012 | 11.02% |
| Jun 30, 2012 | 1.88% |
| Mar 31, 2012 | -56.44% |
| Dec 31, 2011 | 125.34% |
| Sep 30, 2011 | -23.07% |
| Jun 30, 2011 | 91.56% |
| Mar 31, 2011 | -1.12% |
| Dec 31, 2010 | -49.50% |